ANAPC1: Regulating Meiosis and Cellular Signaling Pathways (G64682)

Target Name: ANAPC1

NCBI ID: G64682

ANAPC1

ANAPC1: Regulating Meiosis and Cellular Signaling Pathways

The Anaphase-Promoting Complex (APC) 1 (ANAPC1) is a protein that plays a critical role in regulating meiosis, the process by which a cell divides. Meiosis is a crucial process for the development and maintenance of genetics diversity, and ANAPC1 is involved in ensuring that meiosis proceeds in an orderly and accurate manner.

ANAPC1 is a member of the T-cell nuclear factor (TNF) signaling pathway, which is a well-established pathway for cell signaling and division. The TNF signaling pathway is involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

ANAPC1 functions as a negative regulator of the TP53 gene, which is a well-established gene that plays a critical role in the regulation of apoptosis (programmed cell death). TP53 is a tumor suppressor gene that is often mutated in cancer, and ANAPC1 is involved in ensuring that TP53 function is properly regulated.

ANAPC1 is also involved in the regulation of the chromatin structure of meiosis. Meiosis is a process that involves the separation of homologous chromosomes from a cell, which is critical for the genetic diversity that is generated by cell division. ANAPC1 is involved in the regulation of the compact chromatin structure that develops during meiosis, ensuring that the correct number of chromosomes are present in each cell.

In addition to its role in regulating meiosis, ANAPC1 is also involved in the regulation of cellular signaling pathways that are important for cell survival. For example, ANAPC1 is involved in the regulation of the Notch signaling pathway, which is involved in the regulation of stem cell proliferation and differentiation.

ANAPC1 is also involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation and cellular signaling. The NF-kappa-B signaling pathway is a well-established pathway that is involved in the regulation of various cellular processes, including inflammation, pain, and stress responses. ANAPC1 is involved in the regulation of the NF-kappa-B signaling pathway, ensuring that it is properly regulated.

ANAPC1 is also involved in the regulation of the PI3K/AKT signaling pathway, which is involved in the regulation of cellular signaling pathways that are important for cell survival. The PI3K/AKT signaling pathway is a well-established pathway that is involved in the regulation of various cellular processes, including cell survival, angiogenesis, and inflammation. ANAPC1 is involved in the regulation of the PI3K/AKT signaling pathway, ensuring that it is properly regulated.

In conclusion, ANAPC1 is a protein that plays a critical role in regulating meiosis, the process by which a cell divides. ANAPC1 is involved in the regulation of TP53 function, chromatin structure, and various cellular signaling pathways that are important for cell survival. Given Its involvement in these critical processes, ANAPC1 is an attractive drug target and a potential biomarker for various diseases.

Protein Name: Anaphase Promoting Complex Subunit 1

Functions: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains

The "ANAPC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANAPC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets